Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
After achieving primary endpoint by demonstrating superiority and non-inferiority in HbA1C reduction from baseline at…
OKSPOT Unveils Privacy-Focused Crypto Exchange for Global Traders With No-KYC Registration and Monero Support
Mambu and Mastercard expand cross-border payment capabilities for banks across APAC
Indonesia’s ITS Celebrates 66th Anniversary and Officially Closes KSTI 2026
Shaping the Future Together: Voices from Around the World at the III International Symposium ‘Creating the Future’ in Russia
The UAE’s AI Adoption Is a World Record. Paying for It Is Another Story